{"id":"NCT02062463","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma","officialTitle":"A 12-Week, Randomized, Open-Label, Parallel-Group Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® (160/4.5 and 320/9 mcg) as Compared With SYMBICORT® TURBOHALER® (200/6 and 400/12 mcg) as Treatment for Adult Patients With Asthma (The Easy Low Instruction Over Time [ELIOT] Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-28","primaryCompletion":"2015-03-13","completion":"2015-03-13","firstPosted":"2014-02-13","resultsPosted":"2024-03-22","lastUpdate":"2024-03-22"},"enrollment":485,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX","otherNames":["SPIROMAX®"]},{"type":"DRUG","name":"SYMBICORT TURBOHALER budesonide and formoterol fumarate","otherNames":["SYMBICORT®","TURBOHALER®"]}],"arms":[{"label":"Stage 1: Empty Spiromax Followed by Empty Turbohaler","type":"NO_INTERVENTION"},{"label":"Stage 1: Empty Turbohaler Followed by Empty Spiromax","type":"NO_INTERVENTION"},{"label":"Stage 2: BF Spiromax","type":"EXPERIMENTAL"},{"label":"Stage 2: Symbicort Turbohaler","type":"ACTIVE_COMPARATOR"}],"summary":"This study is conducted to assess whether training participants on proper use of BF SPIROMAX and Symbicort TURBOHALER will improve their device-handling technique and potentially improve their treatment outcome, that is, better asthma control.","primaryOutcome":{"measure":"Stage 1: Percentage of Participants Achieving Device Mastery","timeFrame":"Baseline (Day 1)","effectByArm":[{"arm":"Stage 1: Empty Spiromax","deltaMin":94.4,"sd":null},{"arm":"Stage 1: Empty Turbohaler","deltaMin":86.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":74,"countries":["United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":197},"commonTop":["Lower respiratory tract infection","Cough"]}}